Funding Opportunities for Test Method Developers
NICEATM and ICCVAM seek to facilitate development of test methods that replace, reduce, and refine the use of animals in testing. In addition, both organizations are committed to the protection of human health, animal health, and the environment. This page lists announcements of funding opportunities intended to support the development of alternative test methods. If you are aware of a funding opportunity that could be included on this page, please contact NICEATM.
SBIR and STTR Omnibus Grant Solicitations of the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration
NIEHS is offering funding for small businesses developing technologies of interest to the Tox21 program. These technologies include:
- Improved or expanded testing methods for toxicity screening
- Computational approaches for predictive toxicology
- Technologies such as alternative or improved methods for fixing and preserving tissues
The funding is being offered as part of the 2019 Omnibus Solicitation of the NIH, CDC, and Food and Drug Administration. This funding is available for small business grant applications to support development and commercialization of innovative technologies. View more information on the NIEHS website.
SBIR/STTR Omnibus Solicitations and Accompanying Resources
- Solicitation notices on NIH website (posted May 8, 2019)
- Program Descriptions and Research Topics
- Appendix A (SBA approved topics for budget waivers)
- Application Guide for SBIR/STTR Grant Applications
Next due date: September 5, 2019
For more information about this opportunity, contact:
NIH Funding Resources
The NIEHS SBIR/STTR Program Staff encourages applicants to submit grants at least one week before the deadline and to take advantage of the following resources:
- NIH "All About Grants" Podcast on the Office of Extramural Research website
- NIH RePORTER Matchmaker – useful for an initial screen for matching your technology to an institute and a relevant study section for review. It is also a great place to better understand what types of technologies NIH institutes fund.
- NIH Grants Policy Statement – rules for applying for and accepting a grant
- Frequently Asked Questions about SBIR and STTR grants on the NIH website
- Frequently asked questions about SBIR/STTR grants in general
- Annotated SBIR/STTR SF424 application forms
- Webinar series for funding opportunities for environmental technologies
- NIH study section identifier – allows you to search your topic of interest
- Application cover letters are optional but provide you an opportunity to designate an institute or study section
- Rules for calculating number of employees
- Registration and application instructions (this process can take six to eight weeks and should be initiated well before the deadline)
- Top five eRA Commons errors
NIH Commercialization Readiness Pilot Program
The NIH Commercialization Readiness Pilot program facilitates the commercialization of previously funded SBIR and STTR Phase II and Phase IIB projects by funding activities not typically supported through Phase II or Phase IIB grants or contracts. Small businesses that have had an active NIH SBIR or STTR Phase II or Phase IIB award within the last 36 months are eligible to apply. Awardees will receive up to $300,000. Standard SBIR/STTR application deadlines apply for these grants; the next deadline is September 5.
Grants Available to Support Alternative Methods for Vaccine Testing
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is offering $1.5 million in grants to develop and implement innovative technologies for vaccine and biological manufacturing. A major area of interest is development of alternative in vitro assays to reduce the reliance on animal testing required for lot release.
Those interested in applying for these grants must submit a four-page concept paper by September 10. This paper should present an overview of the proposed project; no teaming, detailed budget, or cost share information is required. Following submission of concept papers, invitations will be issued to participate in the Project Call 3.1 Summit in October. At this event, proposers will have opportunities to network and discuss their project. This phase will conclude with invitations issued to submit a full proposal in Stage 2 of the process.
More information about the funding opportunity, including slides from a July 23 webinar, is available on the NIIMBL website. This funding opportunity is supported by the NIIMBL Global Health Fund, a collaboration between NIIMBL and the Bill & Melinda Gates Foundation.
PCRM Offers Student Travel Award
The Physicians Committee for Responsible Medicine (PCRM) is offering $1000 to support attendance of an outstanding undergraduate or graduate student at the Annual Biomedical Research Conference for Minority Students (ABRCMS) in November.
Applicants for the PCRM travel award must be attending an accredited U.S. higher learning institution. They must have had an abstract accepted at ABRCMS that describes human-relevant research using microphysiological systems, bioengineering, computational modeling, organoids, or other non-animal approaches. Projects using or suggesting future use of animals are not eligible. Applications will be evaluated in part on the student’s demonstrated interest in ethical sciences and commitment to pursue a career using non-animal methods. Applications are due September 6.
NIH to Fund Studies to Improve iPSC Reproducibility
NIH is offering SBIR grants to develop methods that improve the reproducibility of human induced pluripotent stem cell (iPSC) derivation, growth, and differentiation. Eligible projects should seek to address the significant variability currently observed in human iPSCs in reprogramming efficiency, differentiation potential, and cell growth and stability, which is limiting the full potential of these tools for research and clinical practice. Eleven NIH Institutes and centers, including NIEHS, intend to commit funds to this effort, with an estimated 25 awards to be awarded to U.S. small businesses. Applications will be accepted from December 6, 2019 through January 6, 2020.
NAS Graduate Fellowships Available, Apply by September 6
Applications are being accepted through September 6 for the Christine Mirzayan Science and Technology Policy Graduate Fellowship Program, a full-time educational program for early career individuals. Fellows will spend 12 weeks in early 2020 at the National Academies of Sciences, Engineering, and Medicine (NAS) in Washington, DC, learning about science and technology policy and the role that scientists and engineers play in advising the nation. The fellowship offers a unique opportunity to obtain the essential skills and knowledge needed to work in science policy at the federal, state, or local levels.
Applicants should be current graduate or professional school students, or have received degrees within the last five years. Applicants need not be U.S. citizens but must be legal residents of the U.S.; NAS does not sponsor visas for the fellowship program. Applicants must provide two references relevant to their academic or professional experience before applications will be accepted.
EPAA Accepting Applications for 2019 Refinement Prize
The European Partnership for Alternative Approaches to Animal Testing (EPAA) is a collaboration among the European Commission, European trade associations, and industry to accelerate the development, validation, and acceptance of alternative approaches to animal use in regulatory testing. EPAA is accepting applications for the 2019 EPAA Refinement Prize. This prize recognizes a laboratory technician, animal caretaker, or technologist who has demonstrated outstanding achievements in advancing implementation or raising awareness of new refinements for animal testing. A €6000 prize will be awarded to recognize an individual or a team. Applicants must work in a European Union or neighboring country. Awardees will be expected to attend the EPAA annual conference on October 29. The application deadline is September 2.